New Jersey Assembly Bill A4180

New Jersey 2026-2027 Regular Session

• Introduced: 2/19/26
• Refer: 2/19/26

Caption

Shifts $45 million appropriation for opioid related care and treatment provided at certain hospitals from Opioid Recovery and Remediation Fund to General Fund.

Impact

By appropriating these funds directly from the General Fund, A4180 aims to ensure that healthcare institutions can provide consistent and necessary treatment to victims of opioid abuse. The funds will be distributed among several hospitals, including Hackensack, RWJ Barnabas, Cooper, and Atlantic Health, enabling them to address the growing opioid crisis through targeted care. Each of these institutions will have the responsibility to report quarterly on fund usage, including details on the number of individuals served and their treatment outcomes.

Summary

Bill A4180, introduced in the New Jersey Assembly, proposes a significant shift regarding how opioid-related funds are allocated. Specifically, the bill reallocates a $45 million appropriation for opioid care and treatment from the Opioid Recovery and Remediation Fund to the General Fund, designed to enhance the funding available for hospitals treating opioid-related issues. This provision marks a strategic move to streamline and potentially stabilize funding sources for opioid treatment initiatives across the state.

Contention

A notable point of contention surrounding A4180 is the removal of Section 111 of P.L.2025, which originally provided for the same appropriation from the Opioid Recovery and Remediation Fund. Critics may argue that this change represents a significant policy shift, potentially undermining the original intent of utilizing these funds specifically dedicated to opioid recovery efforts, which was sourced from settlements with pharmaceutical companies liable for the opioid epidemic. This could lead to debates about the sustainability and effectiveness of treatment funding in the long term.